Global X Management Company’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
$1.26M Buy
17,734
+534
+3% +$37.7K 0.02% 405
2018
Q1
$1.3M Buy
17,200
+1,562
+10% +$124K 0.03% 356
2017
Q4
$1.12M Buy
15,638
+2,133
+16% +$162K 0.03% 338
2017
Q3
$1.09M Buy
13,505
+870
+7% +$66.5K 0.03% 332
2017
Q2
$894K Buy
12,635
+1,018
+9% +$67.7K 0.03% 372
2017
Q1
$789K Buy
11,617
+2,495
+27% +$175K 0.03% 365
2016
Q4
$653K Buy
9,122
+271
+3% +$20.1K 0.03% 335
2016
Q3
$700K Buy
8,851
+8,359
+1,699% +$679K 0.03% 300
2016
Q2
$41K Buy
492
+202
+70% +$17.9K ﹤0.01% 758
2016
Q1
$27K Buy
290
+108
+59% +$9.74K ﹤0.01% 718
2015
Q4
$18K Buy
182
+2
+1% +$208 ﹤0.01% 509
2015
Q3
$18K Sell
180
-68
-27% -$7.55K ﹤0.01% 500
2015
Q2
$29K Buy
248
+43
+21% +$4.7K ﹤0.01% 457
2015
Q1
$20K Sell
205
-26
-11% -$2.64K ﹤0.01% 470
2014
Q4
$22K Buy
231
+54
+31% +$5.58K ﹤0.01% 449
2014
Q3
$19K Sell
177
-187
-51% -$18.3K ﹤0.01% 475
2014
Q2
$30K Hold
364
﹤0.01% 394
2014
Q1
$26K Sell
364
-120
-25% -$9.41K ﹤0.01% 396
2013
Q4
$36K Hold
484
﹤0.01% 353
2013
Q3
$30K Buy
+484
New +$28.9K ﹤0.01% 350

Other funds holding GILD

Global X Management Company's GILD Position: Q2 2018 in Review

Global X Management Company increased its Gilead Sciences (GILD) stake by 3.1% in Q2 2018, buying an estimated $37.7K and bringing the position to 17,734 shares worth $1.26M. The position accounts for 0.02% of the portfolio, ranked #405.

Global X Management Company first reported a position in GILD in Q3 2013 and has held it in 20 quarters since. The position peaked at $1.3M in Q1 2018. 1,522 funds tracked by Wall St. Rank hold GILD as of Q2 2018.

  • Global X Management Company held 17,734 shares of Gilead Sciences worth $1.26M as of Q2 2018.
  • Global X Management Company bought 534 Gilead Sciences shares in Q2 2018, an estimated $37.7K.
  • Gilead Sciences made up 0.02% of Global X Management Company's portfolio in Q2 2018, its #405 holding.
  • Global X Management Company first reported a position in Gilead Sciences in Q3 2013 and has held it in 20 quarters since.
  • Global X Management Company's Gilead Sciences position peaked at $1.3M in Q1 2018.
  • 1,522 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2018.

Based on Global X Management Company's 13F filing for Q2 2018, filed 16 Aug 2018.